BR9811709A - Polipeptìdeos modificados com alta atividade e reduzida alergenicidade - Google Patents

Polipeptìdeos modificados com alta atividade e reduzida alergenicidade

Info

Publication number
BR9811709A
BR9811709A BR9811709-2A BR9811709A BR9811709A BR 9811709 A BR9811709 A BR 9811709A BR 9811709 A BR9811709 A BR 9811709A BR 9811709 A BR9811709 A BR 9811709A
Authority
BR
Brazil
Prior art keywords
enzyme
twinned
reduced allergenicity
modified
group
Prior art date
Application number
BR9811709-2A
Other languages
English (en)
Inventor
David Weisgerger
Donn Nelton Rubingh
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9811709A publication Critical patent/BR9811709A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38627—Preparations containing enzymes, e.g. protease or amylase containing lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"POLIPEPTìDEOS MODIFICADOS COM ALTA ATIVIDADE E REDUZIDA ALERGENICIDADE". A presente invenção refere-se a um polipeptídeo modificado que tem um nível de atividade enzimática maior do que cerca de 70% do polipeptídeo original e um nível de resposta alergênica menor do que cerca de 33% do polipeptídeo original. As modalidades da presente invenção referem-se a polipeptídeos modificados com reduzida alergenecidade e alta atividade enzimática, que compreendem a fórmula: A-B~ n~, onde A é uma enzima, e suas misturas; B é um grupamento polimérico geminado que tem um peso molecular entre cerca de 0,5 quilodaltons (kd) e cerca de 40 kd, tendo a fórmula (1), conjugado à enzima, onde R~ 1~ e R~ 2~ são polímeros com cadeia essencialmente linear, tendo um peso molecular na faixa entre cerca de 0,25 kd e cerca de 20 kd; onde a relação entre os pesos moleculares de R~ 1~ e R~ 2~ é entre cerca de 1:10 e cerca de 10:1; onde X é um grupamento ligante que liga o grupamento geminado a um único sítio da enzima, e n é o número de grupamentos poliméricos geminados conjugados à enzima, e representa um número inteiro entre cerca de 1 e cerca de 15.
BR9811709-2A 1997-07-30 1998-07-23 Polipeptìdeos modificados com alta atividade e reduzida alergenicidade BR9811709A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/903,298 US6284246B1 (en) 1997-07-30 1997-07-30 Modified polypeptides with high activity and reduced allergenicity
PCT/US1998/015282 WO1999006071A1 (en) 1997-07-30 1998-07-23 Modified polypeptides with high activity and reduced allergenicity

Publications (1)

Publication Number Publication Date
BR9811709A true BR9811709A (pt) 2000-07-25

Family

ID=25417259

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9811709-2A BR9811709A (pt) 1997-07-30 1998-07-23 Polipeptìdeos modificados com alta atividade e reduzida alergenicidade

Country Status (12)

Country Link
US (1) US6284246B1 (pt)
EP (1) EP1005373A1 (pt)
JP (1) JP2001511461A (pt)
KR (1) KR20010022419A (pt)
CN (1) CN1268062A (pt)
AR (1) AR016561A1 (pt)
AU (1) AU8583498A (pt)
BR (1) BR9811709A (pt)
CA (1) CA2297437A1 (pt)
CO (1) CO4810246A1 (pt)
WO (1) WO1999006071A1 (pt)
ZA (1) ZA986756B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
US6495136B1 (en) * 1998-03-26 2002-12-17 The Procter & Gamble Company Proteases having modified amino acid sequences conjugated to addition moieties
US6458953B1 (en) * 1998-12-09 2002-10-01 La Jolla Pharmaceutical Company Valency platform molecules comprising carbamate linkages
CN1762990A (zh) * 1999-06-08 2006-04-26 拉卓拉药物公司 包含氨基氧基的化合价平台分子
TW586945B (en) 2001-01-12 2004-05-11 Novartis Ag Lens care product containing dexpanthenol
US20040007251A1 (en) * 2002-07-10 2004-01-15 Kimberly-Clark Worldwide, Inc. Cleaners for the control and removal of allergens
WO2004014973A2 (en) * 2002-08-13 2004-02-19 Sirus Pharmaceuticals Ltd Biodegradable polymer
US20070134335A1 (en) * 2005-06-08 2007-06-14 Lledo Ernest G Polypeptides with the capacity to entrap drugs and release them in a controlled way
CA2624667C (en) 2005-10-05 2018-01-09 Commonwealth Scientific And Industrial Research Organisation Silk proteins containing coiled coil region
US8674077B2 (en) 2009-08-26 2014-03-18 Commonwealth Scientific And Industrial Research Organisation Processes for producing silk dope
JP6317258B2 (ja) 2011-11-16 2018-04-25 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション コラーゲン様絹遺伝子
EP2850191A4 (en) 2012-03-26 2016-03-23 Commw Scient Ind Res Org SILK POLYPEPTIDES

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
DE2631656C2 (de) 1976-07-14 1983-02-10 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung eines Hydroxysuccinimidoester-Derivats zur Bindung von biologisch aktiven Proteinen aneinander und/oder an flüssige oder feste Trägerstoffe
US4556554A (en) 1981-06-01 1985-12-03 Germaine Monteil Cosmetiques Corp. Immobilized enzymes
US4760025A (en) 1984-05-29 1988-07-26 Genencor, Inc. Modified enzymes and methods for making same
US5185258A (en) 1984-05-29 1993-02-09 Genencor International, Inc. Subtilisin mutants
DE3675588D1 (de) 1985-06-19 1990-12-20 Ajinomoto Kk Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
US4980288A (en) 1986-02-12 1990-12-25 Genex Corporation Subtilisin with increased thermal stability
DE3750916T2 (de) 1986-04-30 1995-06-01 Genencor Int Mutante einer nicht menschlichen Carbonyl-Hydrolase, für diese kodierende DNS-Sequenzen und Vektoren und durch diese Vektoren transformierte Wirte.
JP2546807B2 (ja) * 1988-09-30 1996-10-23 鐘紡株式会社 化粧料
US5122614A (en) 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
GB8915658D0 (en) 1989-07-07 1989-08-23 Unilever Plc Enzymes,their production and use
US5030378A (en) 1990-01-02 1991-07-09 The Procter & Gamble Company Liquid detergents containing anionic surfactant, builder and proteolytic enzyme
US5230891A (en) * 1990-08-20 1993-07-27 Kanebo Limited Modified protease, method of producing the same and cosmetic products containing the modified protease
US5133968A (en) 1990-08-20 1992-07-28 Kanebo, Ltd. Modified protease, method of producing the same and cosmetic products containing the modified protease
DE69130113T2 (de) 1990-12-05 1999-05-12 Novo Nordisk As Proteine mit geänderten epitopen und verfahren zur deren herstellung
EP0516200B1 (en) 1991-05-01 1996-07-24 Unilever N.V. Detergent compositions containing stabilized enzymes
IT1260468B (it) 1992-01-29 1996-04-09 Metodo per mantenere l'attivita' di enzimi proteolitici modificati con polietilenglicole
GB9207280D0 (en) 1992-04-02 1992-05-13 Unilever Plc Skin care method and composition
GB9207288D0 (en) 1992-04-02 1992-05-13 Unilever Plc Cosmetic composition
US5470733A (en) 1993-06-01 1995-11-28 University Of Maryland Calcium free subtilisin mutants
US6436690B1 (en) 1993-09-15 2002-08-20 The Procter & Gamble Company BPN′ variants having decreased adsorption and increased hydrolysis wherein one or more loop regions are substituted
MA23346A1 (fr) 1993-10-14 1995-04-01 Genencor Int Variantes de la subtilisine
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5446090A (en) 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
ZA952220B (en) 1994-05-02 1995-12-14 Procter & Gamble Bpn' variants having decreased adsorption and increased hydrolysis wherein one or more loop regions are substituted
US6599730B1 (en) 1994-05-02 2003-07-29 Procter & Gamble Company Subtilisin 309 variants having decreased adsorption and increased hydrolysis
WO1996017929A1 (en) 1994-12-07 1996-06-13 Novo Nordisk A/S Polypeptide with reduced allergenicity
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
DE69631329T2 (de) 1995-03-10 2004-11-18 Sumitomo Pharmaceuticals Co., Ltd. Menschlicher wachstumsfaktor (hgf), verändert durch polyethylenglykol
AU5893696A (en) 1995-06-07 1996-12-30 Novo Nordisk A/S Modification of polypeptides
JPH11502256A (ja) * 1995-12-29 1999-02-23 ザ、プロクター、エンド、ギャンブル、カンパニー 固定化酵素を含有する洗剤組成物
US6159688A (en) 1997-03-18 2000-12-12 Novo Nordisk A/S Methods of producing polynucleotide variants

Also Published As

Publication number Publication date
CA2297437A1 (en) 1999-02-11
CN1268062A (zh) 2000-09-27
AR016561A1 (es) 2001-07-25
CO4810246A1 (es) 1999-06-30
WO1999006071A1 (en) 1999-02-11
JP2001511461A (ja) 2001-08-14
ZA986756B (en) 1999-02-10
US6284246B1 (en) 2001-09-04
AU8583498A (en) 1999-02-22
EP1005373A1 (en) 2000-06-07
KR20010022419A (ko) 2001-03-15

Similar Documents

Publication Publication Date Title
BR9811709A (pt) Polipeptìdeos modificados com alta atividade e reduzida alergenicidade
DE69027950D1 (de) Auf Polyurethan basierende Polymermaterialien und diese verwendende biomedizinische Artikel und pharmazeutische Zusammensetzungen
BR0113608A (pt) Composição cosmética clara em emulsão antiperspirante e/ou desodorante
DE69914928D1 (de) Polymerkomplexe von glukuronoglukanen
DE69613481T2 (de) Hydrogele auf basis von dreiblockcopolymerisate, ihre herstellung und ihre verwendung
BR9712969A (pt) Gel sensìvel à temperatura para distribuição sustentada de drogas de proteìnas
BR0307893A (pt) Formulação oftálmica com sistema de goma
DE68919061D1 (de) Verbindungen.
MXPA04006091A (es) Composiciones polimericas fotocromicas y articulos de las mismas.
EP0997482A4 (en) MODIFIED CYCLOOLEFIN ADDITION POLYMER AND CURABLE RESIN COMPOSITION BASED ON SAID POLYMER
ES2159769T3 (es) Polimero en bloque lineal que comprende grupos urea y uretano, procedimiento para producirlo y su utilizacion en forma de implantes.
DK98285A (da) Gummi/gelatine-blanding
BR0300522A (pt) Composições, contendo elastÈmeros e polietilenos com alto peso molecular com forma de partìculas irregular,processos para a sua preparação e sua aplicação
BR9814764A (pt) Composição aquosa, uso da mesma, e, substrato.
BR9814760A (pt) Proteìna anticongelamento, sequência de ácido nucléico, e, produto alimentìcio.
DE69811061D1 (de) Kosmetische zusammensetzungen enthaltend ein kationisches polymer mit niedrigem molekulargewicht und einem silikon sowie deren verwendungen
ATE358161T1 (de) Thermoplaste mit verbesserter flexibilität und transparenz
FI893681A0 (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
DE58903499D1 (de) Fuellstoffe.
ES2037858T3 (es) Composicion polimera de elevada resistencia al choque.
DE69931261D1 (de) Polymerträger mit polyoxalkylenen
TR199903203A3 (tr) Yüksek oranda seffaf polimerik bilesim.
BR9810210A (pt) Melhoramentos em ou referentes a composiçõespoliméricas
BR9714937A (pt) Material de textura macia e processo para aumentar a capacidade de respiração de um material de textura
DE68914700D1 (de) Polymere Zusammensetzungen und ihre Herstellung.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.

B15K Others concerning applications: alteration of classification

Ipc: C11D 3/386 (2006.01), A61K 8/02 (2006.0